Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | TACR1 | P25103 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2290678 | 1.00 | CA1 (0.44) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL1479599 | 1.00 | CA1 (0.44) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL23292518 | 1.00 | CA1 (0.44) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL19970649 | 0.96 | CA1 (0.45) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL1561831 | 0.96 | CA1 (0.45) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL2562479 | 0.96 | CA1 (0.45) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL3751041 | 0.96 | CA1 (0.45) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL1263178 | 0.96 | CA1 (0.45) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL4833427 | 0.92 | CA1 (0.42) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL5999732 | 0.92 | CA1 (0.42) | CA1CA2CA7CA9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110016006-B | Azacarboside chalcone and preparation method thereof | 合肥亘舒科技有限公司 | 2021-01-12 | — | — | CN | claimed |
| CN-108101946-B | Continuous synthesis method and application of 2,3,4, 6-tetra-oxy-benzylglucose | 凯莱英医药集团（天津）股份有限公司 | 2020-10-23 | — | — | CN | claimed |
| US-8278436-B2 | Glycosylated warfarin analogs and uses thereof | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-10-02 | — | — | US | claimed |
| US-20100267655-A1 | Glycosylated Warfarin Analogs and Uses Thereof | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-10-21 | — | — | US | claimed |
| WO-2010014814-A2 | GLYCOSYLATED WARFARIN ANALOGS AND USES THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-02-04 | — | — | WO | claimed |
| US-5571795-A | GLYCOSYLATED STEROIDS COUPLED TO A DRUG, TRANSPORTATION ACROSS BIOLOGICAL MEMBRANES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1996-11-05 | — | — | US | claimed |
| US-5455335-A | Glycosylated steroids | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1995-10-03 | — | — | US | claimed |
| JP-55105667-A | — | — | None | — | — | JP | disclosed |
| CN-116119833-B | Nutrient for water recovery system and preparation method and application thereof | 嘉兴沃特泰科环保科技股份有限公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-116425809-A | Preparation method of fluorosugar | 复旦大学 | 2023-07-14 | — | — | CN | disclosed |
| CN-116119833-A | Nutrient for water recovery system and preparation method and application thereof | 嘉兴沃特泰科环保科技股份有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-110857285-B | Substituted pyrazole compound, preparation method, pharmaceutical composition and application thereof | 江苏万高药业股份有限公司 | 2022-12-20 | — | — | CN | disclosed |
| CN-113651681-B | Method for preparing aldehyde/ketone by breaking C-C bond | 中山大学 | 2022-07-22 | — | — | CN | disclosed |
| EP-0381070-A1 | Synthetic amphiphilic glycoconjugates for neurological use | FARMHISPANIA S.A. (ES) | 1990-08-08 | — | — | EP | disclosed |
| US-4572907-A | High caloric product for I.V. administration | ABBOTT LABORATORIES (US) | 1986-02-25 | — | — | US | disclosed |
| EP-0002588-B1 | PLEUROMUTILIN GLYCOSIDE DERIVATIVES, FORMULATIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION | ELI LILLY AND COMPANY (US) | 1983-04-06 | — | — | EP | disclosed |
| JP-S55105667-A | GLUCONIC LACTAM DERIVATIVE | NIPPON SHINYAKU CO LTD | 1980-08-13 | — | — | JP | disclosed |
| EP-0002588-A1 | Pleuromutilin glycoside derivatives, formulations containing them and processes for their preparation | ELI LILLY AND COMPANY (US) | 1979-06-27 | — | — | EP | disclosed |
| US-4130709-A | BACTERICIDE | ELI LILLY AND COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4021542-A | Derivatives of hydrazino-monosaccharides and aldohexoses which are useful as intermediates for preparing compounds or as compounds which lower the uric acid | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DT) | 1977-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267655-A1 | Glycosylated Warfarin Analogs and Uses Thereof | GPI, UGGT1, GALE | CA1 1319/4885CA2 1528/4885CA7 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.